Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.

ABSTRACT:

Background

Historically, published guidelines for care after molar pregnancy recommended monitoring human chorionic gonadotropin levels for the development of gestational trophoblastic neoplasia until normal and then for 6 months after the first normal human chorionic gonadotropin. However, there are little data underlying such recommendations, and recent evidence has demonstrated that gestational trophoblastic neoplasia diagnosis after human chorionic gonadotropin normalization is rare.

Objective

We sought to estimate the cost-effectiveness of alternative strategies for surveillance for gestational trophoblastic neoplasia after human chorionic gonadotropin normalization after complete and partial molar pregnancy.

Study design

A Markov-based cost-effectiveness model,

SUBMITTER: Albright BB 

PROVIDER: S-EPMC9941751 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature